Live Breaking News & Updates on Eper Spray

Stay updated with breaking news from Eper spray. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pepper Spray A Dangerous Weapon, Can't Be Used For Private Defense When There's No Imminent Threat Or Danger Caused To Life: Karnataka High Court

The Karnataka High Court refused to quash a criminal case against C Ganesh Narayan, the Director of C.Krishniah Chetty & Company Private Limited and his wife accused of using pepper spray on the. ....

United States , State Of Karnataka , Livelaw Kar , Rajdeep Das , C Ganesh Narayan , Sandeshj Chouta , Vinod Hayagriv , Krutika Raghavan , Justicem Nagaprasanna , Karnataka High Court , Apex Court , C Krishniah Chetty Company Private , Company Private Limited , Senior Advocate Sandeshj Chouta , Advocate Krutika Raghavan , Eper Spray , Self Defence ,

Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update

Trudhesa® Achieved nTRx of Over 18.5K in Q1 2023; Increase of 112% vs. Q1 2022 Trudhesa Net Product Revenue in Q1 2023 Increased 149% vs. Q1 2022 to $4.4 Million Impel to Host Investor. | May 12, 2023 ....

United States , Darren Cline , Christina Tartaglia , Michaelw Kalb , Adrian Adams , Melyssa Weible , Impel Pharmaceuticals Inc , American Academy Of Neurology , Exchange Commission , Cincor Pharma Inc , Elixir Health Public Relations , Impel Pharmaceuticals , Company Developments , Development Rd Expenses , Net Product Revenue , Host Investor Conference Call Today , Chief Executive Officer , Dihydroergotamine Mesylate , Nasal Spray , Eper Spray , Annual Meeting , Chief Financial Officer , Executive Vice President , Cincor Pharma , First Quarter , Product Revenue ,

Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Trudhesa® Achieved nTRx of Over 58.4K in 2022; nTRx Increased by 19.4% in Q4 vs. Q3 2022 Net Product Revenue Finished Year at $12.7 Million; Increased 62% in Q4 vs. Q3 2022 to $5 Million Impel. | March 24, 2023 ....

United States , Melyssa Weible , Adrian Adams , December Trudhesa , Janhavi Mohite , Drug Administration , American Headache Society , Exchange Commission , Impel Pharmaceuticals Inc , American Academy Of Neurology , Development Rd Expenses , Elixir Health Public Relations , Impel Pharmaceuticals , Product Revenue Finished Year , Host Investor Conference Call Today , Chief Executive Officer , Dihydroergotamine Mesylate , Nasal Spray , Eper Spray , New Trudhesa , American Academy , Annual Meeting , Annual Scientific Meeting , Aerosol Medicine , Pulmonary Drug Delivery , Precision Olfactory Delivery ,

Impel Pharmaceuticals Announces Second Quarter 2022 Financial Results and Provides Corporate Update

15.08.2022 - Trudhesa TRx’s Grew 48% in Q2 2022 to Over 13K: Net Product Revenue Increased 59% Over Q1 2022 to $2.8 Million Sales Force Expanded by 50% to Capitalize on Prescription Momentum and Market Opportunity Company Reiterated Prescription Guidance Range . ....

United States , Adrian Adams , Christina Tartaglia , Melyssa Weible , Trudhesa Dihydroergotamine Mesylate , Company Reiterated Prescription Guidance , Impel Pharmaceuticals , Exchange Commission , Development Rd Expenses , Impel Pharmaceuticals Inc , American Headache Society , Elixir Health Public Relations , Clinical Development , Company Reiterated Prescription Guidance Range , Proof Of Concept Study , Autism Spectrum , Host Investor Conference Call Today , Chief Executive Officer , Prescription Olfactory Delivery , Dihydroergotamine Mesylate , Nasal Spray , Eper Spray , Second Quarter , Product Revenues , Loss Per Share , Forma Net Loss Per Share ,